These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34497)

  • 1. Contribution of 4-hydroxy-alprenolol to adrenergic beta receptor blockade of alprenolol.
    Collste P; Borg KO; Aström H; von Bahr C
    Clin Pharmacol Ther; 1979 Apr; 25(4):416-22. PubMed ID: 34497
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of pentobarbital on effect and plasma levels of alprenolol and 4-hydroxy-alprenolol.
    Collste P; Seideman P; Borg KO; Haglund K; von Bahr C
    Clin Pharmacol Ther; 1979 Apr; 25(4):423-7. PubMed ID: 428186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in man.
    Ablad B; Borg KO; Johnsson G; Regårdh CG; Sölvell L
    Life Sci; 1974 Feb; 14(4):693-704. PubMed ID: 4823626
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
    Regårdh CG
    Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.
    Collste P; Haglund K; Frisk-Holmberg M; Rawlins MD
    Eur J Clin Pharmacol; 1976 Jun; 10(2):85-8. PubMed ID: 9292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.
    Regardh CG; Ablad B; Borg KO; Johnsson G; Solvell L
    Acta Pharm Suec; 1974 Dec; 11(6):660. PubMed ID: 237405
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
    Shand DG
    Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 9. Pineal beta adrenergic receptor: correlation of binding of 3H-l-alprenolol with stimulation of adenylate cyclase.
    Zatz M; Kebabian JW; Romero JA; Lefkowitz RJ; Axelrod J
    J Pharmacol Exp Ther; 1976 Mar; 196(3):714-22. PubMed ID: 4608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prolonged beta-blockade on energy metabolism and adrenergic responses in the rat.
    Harri MN
    Med Biol; 1977 Oct; 55(5):268-76. PubMed ID: 592903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of action of beta-blocking drugs.
    Carruthers SG; Kelly JG; McDevitt DG; Shanks RG; Walsh MJ
    Br Med J; 1973 Apr; 2(5859):177. PubMed ID: 4144672
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity and duration of action of pindolol and alprenolol compared in healthy volunteers.
    Aellig WH
    Eur J Clin Pharmacol; 1978 Dec; 14(5):305-8. PubMed ID: 729623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac effects of beta-adrenergic receptor antagonists.
    Ablad B; Carlsson B; Carlsson E; Dahlöf C; Ek L; Hultberg E
    Adv Cardiol; 1974; 12(0):290-302. PubMed ID: 4151859
    [No Abstract]   [Full Text] [Related]  

  • 15. Impairment of physical performance after treatment with beta blockers and alpha blockers.
    Bengtsson C
    Br Med J (Clin Res Ed); 1984 Mar; 288(6418):671-2. PubMed ID: 6141834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
    Heterington DJ; Comerford MB; Nyberg G; Besterman EM
    Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of biological interaction of alprenolol and salicylate in man.
    Johnsson G; Regårdh CG; Sölvell L
    Eur J Clin Pharmacol; 1973 Jun; 6(1):9-14. PubMed ID: 4764375
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug binding to plasma proteins during human pregnancy and in the perinatal period. Studies on cloxacillin and alprenolol.
    Herngren L; Ehrnebo M; Boréus LO
    Dev Pharmacol Ther; 1983; 6(2):110-24. PubMed ID: 6861596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of two different beta-adrenergic blocking agents on the increase in fibrinolytic activity and factor VIII activity during submaximum and maximum exercise.
    Korsan-Bengtsen K; Conradson TB
    Scand J Haematol; 1974; 13(5):377-84. PubMed ID: 4616332
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding of two adrenergic beta-receptor antagonists, alprenolol and H 93-26, to human serum proteins.
    Johansson KA; Appelgren C; Borg KO; Elofsson R
    Acta Pharm Suec; 1974 Sep; 11(4):333-46. PubMed ID: 4153286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.